.

. - .

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2016-001603-23-FR

Enrollment

120

Registered

2016-10-24

Start date

2017-03-08

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: SUFENTANIL Product Name: SUFENTANIL Pharmaceutical Form: Solution for injection INN or Proposed INN: SUFENTANIL CITRATE CAS

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: . Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 80 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 40

Exclusion criteria

Exclusion criteria: .

Design outcomes

Primary

Measure	Time frame
Main Objective: .;Secondary Objective: .;Primary end point(s): .;Timepoint(s) of evaluation of this end point: .	—

Secondary

Measure	Time frame
Secondary end point(s): .;Timepoint(s) of evaluation of this end point: .	—

Countries

France

Contacts

Public ContactInvestigateur Principal

CHU de Clermont-Ferrand

efutier@chu-clermontferrand.fr0033473750476

Outcome results